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ABSTRACT
Mouse embryonic stem (ES) cells are locked into self-renewal by
shielding from inductive cues. Release from this ground state in
minimal conditions offers a system for delineating developmental
progression from naïve pluripotency. Here, we examine the initial
transition process. The ES cell population behaves asynchronously.
We therefore exploited a short-half-life Rex1::GFP reporter to isolate
cells either side of exit from naïve status. Extinction of ES cell identity
in single cells is acute. It occurs only after near-complete elimination
of naïve pluripotency factors, but precedes appearance of lineage
specification markers. Cells newly departed from the ES cell state
display features of early post-implantation epiblast and are distinct
from primed epiblast. They also exhibit a genome-wide increase in
DNA methylation, intermediate between early and late epiblast.
These findings are consistent with the proposition that naïve cells
transition to a distinct formative phase of pluripotency preparatory to
lineage priming.
KEY WORDS: ES cells, Rex1, Epiblast, Methylome, Pluripotency,
Transcriptome
INTRODUCTION
Epiblast cells, founders of all somatic cells and the germ line, are
formed in the inner cell mass (ICM) on the final day of pre-
implantation development in mice (Boroviak and Nichols, 2014;
Cockburn and Rossant, 2010). This emergent condition of ‘naïve
pluripotency’ (Nichols and Smith, 2009) is characterised by a unique
suite of transcription factors, a hypomethylated genome, and the
ability to give rise directly and clonally to embryonic stem (ES) cells
(Boroviak et al., 2014; Brook and Gardner, 1997; Smith et al., 2012;
Lee et al., 2014; Nichols and Smith, 2012). Upon implantation, ES
cell-forming capacity is abruptly lost, epithelialisation commences,
global gene expression is reconfigured and DNA methylation
increases, which is indicative of a profound cellular transition
(Boroviak et al., 2014, 2015; Auclair et al., 2014; Bedzhov and
Zernicka-Goetz, 2014). Subsequently, egg cylinder epiblast cells are
subject to inductive cues leading up to gastrulation and they become
fated, although not yet lineage committed (Tam and Zhou, 1996;
Osorno et al., 2012; Solter et al., 1970). The late phase of
pluripotency during gastrulation is termed ‘primed’, reflecting the
incipient expression of lineage-specification factors (Nichols and
Smith, 2009; Hackett and Surani, 2014).
Mouse ES cells cultured in serum-free media supplemented
with two chemical inhibitors (2i) of MEK1/2 and GSK3α/β, with
optional addition of the cytokine LIF, are in a uniform condition of
self-renewal termed the ‘ground state’ (Ying et al., 2008). In this
in vitro ground state, ES cells show transcriptional and epigenetic
similarity to naïve pre-implantation epiblast (Ficz et al., 2013;
Habibi et al., 2013; Leitch et al., 2013; Nichols and Smith, 2012;
Boroviak et al., 2015). Upon withdrawal of 2i, ES cells embark on a
path to lineage commitment either in vitro or in vivo when injected
into a pre-implantation embryo (Ying et al., 2008; Dunn et al., 2014;
Marks et al., 2012). Recent studies have begun to explore the
dissolution of naïve pluripotency and the route towards multi-
lineage differentiation in vitro (Buecker et al., 2014; Leeb et al.,
2014; Kurimoto et al., 2015; Thomson et al., 2011; Respuela
et al., 2016; Yang et al., 2014; Betschinger et al., 2013; Davies et al.,
2013; Liu et al., 2015; Acampora et al., 2013). However,
differentiating cultures become heterogeneous (Marks et al.,
2012; Kalkan and Smith, 2014; Buecker et al., 2014; Hayashi
et al., 2011). A means to identify and select cells as they transition
from naïve pluripotency would facilitate experimental resolution.
We previously generated ES cells carrying a Rex1::GFPd2
(RGd2) reporter in which the coding sequence of one allele of Rex1
(gene name Zfp42) is replaced with a GFPd2-IRES-bsd cassette that
produces a destabilised version of GFP protein with a 2-hour half-
life (GFPd2) (Wray et al., 2011). Here, we exploit this reporter to
monitor ES cell exit from naïve pluripotency guided by autocrine
cues in defined adherent culture. We test the utility of the reporter as
a faithful marker of naïve pluripotency and survey transcriptomic,
metabolic and DNAmethylome changes during the initial transition
towards differentiation competence.
RESULTS
The RGd2 reporter is a neutral marker of naïve pluripotency
in the embryo
The Rex1-coding sequence is entirely deleted in the RGd2 allele.
RGd2 ES cells (Wray et al., 2011) were transmitted through the
mouse germline and heterozygous animals were backcrossed twice
to strain 129. Following heterozygous intercrosses, homozygous
mice were healthy and fertile, although slightly under-representedReceived 29 July 2016; Accepted 25 January 2017
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(Table S1). These results confirm previous reports that Rex1 is
dispensable for development (Kim et al., 2011; Masui et al., 2008;
Rezende et al., 2011). We could derive wild-type, heterozygous and
homozygous ES cells, both male and female, from intercross
embryos (Table S2), demonstrating that Rex1 is not significant for
ES cell propagation. RGd2 expression should therefore constitute a
neutral reporter.
We evaluated reporter expression in the embryo by
immunofluorescence staining for GFP. Co-staining for GATA4
revealed that the RGd2 reporter is expressed exclusively and
uniformly throughout the naïve epiblast (Epi) at E4.5 (Fig. 1A),
with no GFP in either GATA4-positive primitive endoderm or
trophoblast. GFP is downregulated during implantation and becomes
undetectable in the epiblast at E5. However, expression is upregulated
in the extra-embryonic ectoderm (ExE) (Fig. 1B). These results are
consistent with Rex1 mRNA expression in the embryo measured by
in situ RNA hybridisation (Pelton et al., 2002), RT-qPCR (Boroviak
et al., 2014) and RNA-seq (Boroviak et al., 2015). We conclude that
the RGd2 allele faithfully reports endogenous Rex1 transcription and
accordingly that GFP expression coincides with naïve pluripotency
in vivo (Boroviak et al., 2014).
Release of ES cells from 2i triggers progression towards
multi-lineage specification
We monitored the early phase of ES cell transition in vitro after
withdrawal from 2i in serum-free N2B27 medium on gelatin-coated
plastic (Fig. 2A). We started from ES cells in 2i alone because LIF
delays the onset of differentiation (Dunn et al., 2014). Plating ES
cells directly in N2B27 at low density (<10,000 cells cm−2) results
primarily in neural differentiation (Ying et al., 2003). However,
when cells were plated at an intermediate density (15,000
cells cm−2) and maintained in 2i for 24 h prior to withdrawal,
numerous brachyury (T ) -positive cells also appeared, indicative of
non-neural specification (Fig. 2B). The latter conditions were used
throughout this study.
Oct4 protein expression did not change substantially for 48 h
after release from 2i (Fig. 2B). Rare cells expressing low levels
of Sox1 were first detected at 48 h (Fig. 2B; panels k,q). By
72 h, clusters of bright Sox1-positive cells that lacked Oct4
emerged (Fig. 2B, panels o,r-t). Occasional Sox1/Oct4-double-
positive cells were found outside these clusters (Fig. 2B;
arrowheads in r-t). T-expressing cells were first detected at 72 h,
mostly in dense clumps that were mutually exclusive with Sox1-
positive clusters (Fig. 2B, m-p). T-positive cells at this stage
were also positive for Oct4 (Fig. 2B; arrowheads in u-w),
consistent with transient co-expression in early primitive streak
and during directed in vitro differentiation (Thomson et al.,
2011; Hoffman et al., 2013).
Fig. 1. Expression of the RGd2 reporter before and after implantation.
(A,B) Immunofluorescent staining for GFP (Rex1GFPd2) (red) and Gata4
(grey) at (A) E4.5 and (B) E5. Arrowheads show GATA4-positive nuclei. Scale
bar: 20 μm. ExE, extra-embryonic ectoderm; Epi, epiblast.
Fig. 2. Multilineage specification of ES cells upon release from 2i.
(A) Protocol for monolayer differentiation of naïve ES cells in N2B27 by
withdrawal of 2i. (B) Immunofluorescent staining for Oct4, Sox1 and
brachyury (T). Lower panels (q-w) show enlarged insets from 48 h and 72 h,
with respective inset number in parentheses. (C,D) RT-qPCR for selected
(C) pluripotency and (D) early post-implantation epiblast markers. Expression
levels are shown as fold change relative to naïve ES cells in C and to 48 h
samples in D. GAPDHwas used for normalisation. Error bars indicate s.d. from
two biological replicates.
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Oct4 mRNA downregulation started after 25 h (Fig. 2C). By
contrast, transcripts for naïve transcription factors (TFs) (Dunn
et al., 2014; Martello and Smith, 2014) declined within the first
25 h. Downregulation of Nanog, Esrrb and Tfcp2l1 initiated before
Rex1 and Klf2. Concurrently, transcripts for early post-implantation
epiblast markers Fgf5, Otx2 and Oct6 (Pou3f1) (Acampora et al.,
2016; Pelton et al., 2002) were upregulated (Fig. 2D). mRNAs for
naïve TFs were eliminated by 48 h (Fig. 2C). Similar results were
observed with multiple ES cell lines (Fig. S1A,B).
These results indicate that, upon release from self-renewal in
defined conditions, ES cells are driven by autocrine signals to
progress from the naïve state to multi-lineage specification in an
orderly sequence. First, naïve TFs are extinguished and markers
diagnostic of post-implantation epiblast are induced.
Subsequently, lineage-specific markers emerge and Oct4 is
downregulated.
Pluripotency factors display individual downregulation
kinetics upon 2i withdrawal
To follow the kinetics of transition following release from 2i, we
monitored the RGd2 reporter by flow cytometry (Fig. 3A). GFP was
expressed unimodally with a log normal distribution in 2i. This tight
peak persisted throughout the first 16 h after withdrawal, although
mean fluorescence rose slightly, possibly owing to a transient
increase in Rex1 mRNA at earlier time points (Fig. 2C, Fig. S1A).
By 25 h, GFP intensity became heterogeneous with many cells
shifted to lower expression. This profile suggests that Rex1 is
downregulated with different kinetics in individual cells. By 48 h,
the majority of cells extinguished GFP. Treatment with the protein
synthesis inhibitor cycloheximide confirmed that the half-life of
GFPd2 is slightly under 2 h in both 2i- and N2B27-cultured ES cells
(Fig. S2A-C). Therefore, observed changes in GFP levels upon 2i
withdrawal should track Rex1 transcription.
Fig. 3. Expression of transcription factors during transition of ES cells. (A) GFP flow cytometry profile at indicated time points post-2i withdrawal (10,000 cells
per time-point). Wild-type ES cells were used as the negative control (neg). (B) Immunofluorescent staining for GFP, Nanog and Otx2. (C) Otx2 versus
Nanog fluorescence intensity per cell in arbitrary units (a.u.), as quantified by Volocity. X and Y intercepts of the red lines mark the cut-off for Nanog- and Otx2-
negative cells, respectively. (D) Distribution of Otx2 expression in Nanog subpopulations. (E) GFP versus Nanog fluorescence intensity per cell. X and Y
intercepts of the red lines mark the cut-off for Nanog- and GFP-negative cells, respectively. (F) Distribution of Nanog expression in Rex1 subpopulations at 25 h.
(G) Immunofluorescent staining for Oct4 and Sox2.
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We compared the expression of the RGd2 reporter with the naïve
TF Nanog and with Otx2, a TF that is upregulated in the peri-
implantation epiblast (Acampora et al., 2013, 2016) (Fig. 3B).
Quantification of fluorescence intensities for Nanog and Otx2 in
single cells across the 25 h time course showed that in 2i almost all
cells expressed Nanog at high or intermediate (mid) levels (Fig. 3C,
D). Otx2 was expressed at low to intermediate (mid) levels in many
cells, but was absent in 23% of cells. Sixteen hours post-2i
withdrawal, GFP remained ubiquitous, Nanog became undetectable
in most cells (72%) and Otx2 was upregulated (Fig. 3B-D). Nanog
and Otx2 were co-expressed at mid or high levels in only 15% of
cells. By 25 h, GFP intensity was heterogeneous, consistent with the
flow cytometry profile. Otx2 was expressed in almost all cells,
although the proportion of Otx2-high cells was lower than at 16 h,
consistent with a relative decrease in Otx2 transcript levels (Fig. 2D).
Nanog persisted in only 7% of cells (Fig. 3D), most of which were in
the Rex1-high fraction (Fig. 3E,F). The overall pattern of Nanog and
Otx2 expression during ES cell progression mirrors dynamics in the
embryo. Nanog is co-expressed with low levels of Otx2 in the naïve
pre-implantation epiblast, but as Nanog is downregulated in the peri-
implantation epiblast, Otx2 is upregulated in a mutually exclusive
fashion (Acampora et al., 2016).
A second naïve pluripotency factor, Tfcp2l1 (Martello et al.,
2013; Ye et al., 2013), was already undetectable in most of the
population by 16 h (Fig. S2D), concomitant with a rapid decrease in
transcripts (Fig. 2C). We also examined Tfe3, a bHLH transcription
factor that supports naïve pluripotency (Betschinger et al., 2013).
Nuclear levels of Tfe3 were also already reduced by 16 h relative to
2i (Fig. S2E,F,G), with Tfe3 becoming mostly cytoplasmic. By
contrast, Oct4 and Sox2 proteins exhibited homogeneous
expression throughout the first 25 h after 2i withdrawal (Fig. 3G).
These results reveal that TFs associated with pluripotency display
individual expression behaviour as ES cells transition from the
ground state. RGd2 downregulation appears to reflect aggregate loss
of naïve TFs against a background of persistent Oct4 and Sox2
expression.
Exit from the ground state occurs asynchronously
To determine the time of exit from the ground state, entire cultures
or subpopulations sorted on the basis of RGd2 expression at
selected time points were re-plated at single cell density in serum/
LIF (serum/L) and 2i/LIF (2i/L). Resulting colonies were stained for
alkaline phosphatase (AP) activity (Fig. 4A).
Serum/L permits proliferation of both naïve ES cells and
differentiating progeny (Marks et al., 2012). Thus, colonies in
serum/L reflect plating efficiency and differentiation propensity.
2i-cultured ES cells and cells from inhibitor-withdrawn cultures
generated similar numbers of colonies, indicating equivalent plating
capacity (Fig. 4B). However, the proportions of colony types
varied. From 2i cells, around 60% of colonies were wholly
undifferentiated, with most of the remainder being mixed and a
few completely differentiated. This heterogeneity is typical of ES
cells plated in serum/L (Wray et al., 2010). The degree of
differentiation increased with duration of 2i withdrawal; only 10%
of colonies formed after 16 h were undifferentiated whereas over
20% were wholly differentiated. In 48 h cultures, 95% of colonies
were differentiated (Wray et al., 2010). Thus, ES cells become
increasingly predisposed to differentiation as the 2i withdrawal
period is prolonged.
In 2i/L, self-renewal is optimal, but differentiating cells are
eliminated and only naïve cells form colonies. Strikingly, the
clonogenic efficiency of 16 h cells in 2i/L was equivalent to that
of ground-state ES cells (Fig. 4B). Thus, the increased propensity
for differentiation detected in serum/L is not matched by loss
of self-renewal potential. However, after 25 h of 2i withdrawal,
clonogenicity in 2i/L was significantly reduced, and by 48 h had
fallen to 10% of the starting level. Therefore, up to 16 h after 2i
withdrawal, self-renewal potential remains intact, despite the
reduction in expression of some naïve TFs, induction of post-
implantation epiblast markers and increased tendency to
differentiate in serum/L. Between 16 h and 25 h, self-renewal
capacity is partially lost, whereas by 48 h, exit from the naïve state is
almost complete across the culture. Thus, exit from the naïve state
proceeds gradually in the ES cell population over an extended
period (≤48 h).
Downregulation of Rex1 tracks loss of ES cell self-renewal
potential
To determine whether the gradual loss of ES cell identity at the
population level is recapitulated at the single cell level, we exploited
flow cytometry to fractionate cells based on RGd2 expression. We
sorted for subpopulations 25 h post-2i withdrawal and then replated
(Fig. 4C,D). In serum/L, colony numbers were relatively constant,
although the proportion of undifferentiated colonies declined with
decreasing GFP. In 2i/L, marked differences in total colony
numbers were evident (Fig. 4D). The GFP-high fraction exhibited
equivalent clonogenicity to 2i cells (Fig. 4B,D), indicating complete
retention of naïve status. However, subpopulations with lower GFP
levels produced progressively fewer colonies. The number of
colonies formed from the GFP-low fraction was only 15% of the
number from 2i or GFP-high cells. Thus, the great majority of this
subpopulation has departed the ES cell state (Fig. 4D). These data
demonstrate that by 25 h the population has become functionally
heterogeneous. Therefore, ES cells transition asynchronously.
To examine how closely exit from the naïve state and
downregulation of Rex1 coincide, we sorted cultures 20 h post-2i
withdrawal, when the first GFP-low cells appear, into GFP-high and
GFP-low subpopulations using the same gates as for 25 h cultures
(Fig. S3A). Clonogenic efficiency of GFP-high cells in 2i/L was
equivalent to ground state ES cells, but was reduced by about 70%
for GFP-low cells (Fig. 4B, Fig. S3A). Thus, the earliest cells that
we could obtain after Rex1 downregulation have mostly exited the
ES cell state. These data suggest that in individual cells the transition
occurs at, or slightly after, loss of Rex1 expression.
We examined whether cell cycle dictates the kinetics of Rex1
downregulation. We stained ES cells with the DNA-binding dye
Hoechst and isolated subpopulations in G1, S and G2/M by flow
cytometry (Fig. S3B). We plated these cells along with stained but
unsorted controls directly in N2B27 at 3×104 cells cm−2, which
approximates the density at the time of 2i withdrawal in our standard
protocol. All populations displayed a similar heterogeneous GFP
distribution 25 h after plating, although the G1 starting subpopulation
showed a marginally narrower range and a slightly lower mean
intensity (Fig. S3C). We conclude that the kinetics of Rex1
downregulation is largely independent of initial cell cycle phase.
For subsequent analyses, we selected and defined cell populations
as follows: 2i- cells represent the ground state; 16 h and 25h-H cells
are in a reversible phase preceding the extinction of ES cell character;
and 25h-L cells are the primary products of exit from naïve
pluripotency (Fig. 4E). Flow cytometry and colony assays confirmed
the reproducibility of this system (Fig. 4F, Fig. S3D,E). Colonies
formed from 16h and 25h-H populations after replating in 2i/L re-
expressed naïve pluripotencymarkers at the same level as 2i cells, and
downregulated Otx2, Oct6 and Fgf5 (Fig. S4A,B), demonstrating that
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the ground state was re-established. Immunoblotting after 2i
withdrawal showed progressive downregulation of Nanog, Esrrb
and Klf4 proteins and decreasing GFP, whereas Oct4 was constant
(Fig. 4G). The difference between 25h-H and 25h-L cells is
particularly interesting: Nanog and Esrrb proteins are almost
undetectable in 25h-L cells and Klf4 is greatly diminished. These
three factors are pivotal members of the ES cell gene regulatory
circuitry (Dunn et al., 2014) and their elimination, together with the
Fig. 4. Downregulation of Rex1 tracks exit from the naïve state. (A) Protocol for sorting and clonogenicity assays. (B) Clonogenicity of cells from 2i and
differentiating subpopulations sorted at indicated time points, plated in serum/LIF (Serum/L) or 2i supplemented with LIF (2i/L). Data are mean±s.d. from two
technical replicates (500 cells were plated). (C) Sorting of 25 h-cultures into four subpopulations based on GFP levels by flow cytometry. Lower plot shows the
GFP profiles of post-sort subpopulations. (D) Clonogenicity of four subpopulations shown in C. Data are mean±s.d. from two technical replicates. (E) Diagram
summarising phases of transition from the naïve state. (F) Clonogenicity of the indicated subpopulations. Data aremean±s.d. from three biological replicates each
with two technical replicates (800 cells were plated). (G) Immunoblot of total cell lysates from sorted subpopulations. β-Tubulin andGapdh are loading controls. (H)
Expression of selected general (red) and naïve (orange) pluripotency and early post-implantation epiblast (blue) markers in single cells measured using the
Fluidigm system. Scale bar represents log2 transformed expression value.
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absence of Tfcp2l1 and nuclear Tfe3 (Fig. S2), is expected to be
sufficient for elimination of self-renewal in 25h-L cells.
To assess further the variation between 25 h-cells, we performed
single cell RT-qPCR for selected genes (Fig. 4H). This analysis
confirmed that general pluripotency factors remained constant or
showed modest changes, whereas naïve TFs and post-implantation
markers in general showed reciprocal expression. Notably, 2i cells
were devoid of Fgf5, Oct6 (Pou3f1), Sox3 and Sox4 transcripts that
are upregulated in the post-implantation epiblast (Boroviak et al.,
2015; Pelton et al., 2002; Acampora et al., 2016). The 25h-H cells
showed variable upregulation of these four markers and
downregulation of no more than three of the naïve TFs. By
contrast, in 25h-L cells all the post-implantation epiblast markers
were co-expressed and at least four of the naïve TFs were
downregulated. These results suggest that decay of ES cell
identity correlates with cumulative loss of naïve TFs and
concomitant cumulative upregulation of factors associated with
early post-implantation epiblast. In the reversible 25h-H population,
these factors are expressed in various combinations without an
evident hierarchy.
Transcriptional changes during transition from naïve
pluripotency
To examine global expression dynamics, we carried out microarray
profiling using three biological replicates. We also performed RNA-
seq on independently derived RGd2 ES cell lines. We found a total
of 8810 genes in the microarray that were differentially expressed
between at least two subpopulations (Table S3). Consistent with the
activation of MEK/ERK and GSK3 upon 2i withdrawal, we
observed changes in the expression of components of the pathway
and transcriptional targets. Activation of MEK/ERK is reflected in
the upregulation of immediate ERK response genes, such as Egr1,
Fos, Myc and Jun (Murphy et al., 2004), and of negative-feedback
regulators Spry2 and the ERK phosphatases Dusp4 and Dusp6
(Fig. 5A). mRNAs for the canonical Wnt targets T, Axin2, Cdx1 and
Cdx2 are detected at low levels in 2i, consistent with inhibition of
Gsk3 (Marucci et al., 2014) (Fig. 5A). Expression is reduced upon
2i withdrawal, indicating reduction of β-catenin-dependent
transcription during transition from the ground state. Lef1 is
upregulated, however, suggesting increased potential for Wnt-
stimulated transcriptional regulation after exit.
KEGG pathway enrichment analysis revealed that highly
upregulated genes in 16 h-cells were associated with cell cycle,
cytoskeleton, steroid synthesis and cell adhesion; and in 25h-L cells
with ribosome biogenesis, RNA processing, DNA replication,
nucleotide metabolism, proteosome, VEGF signalling and MAPK
pathway. Most downregulated in 16h- and 25h-low cells were genes
with functions in lysosomes, oxidative phosphorylation (OxPhos),
glycolysis, glycosylation and glycan degradation. (Fig. 5B). An
overall decrease in transcripts encoding components of
mitochondrial respiratory complexes was confirmed by RNA-seq
(Fig. S5A). The changes encompassed all five mitochondrial
enzyme complexes that mediate electron transport and ATP
synthesis. To investigate metabolic consequences, we measured
oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR), indicators of mitochondrial respiration and glycolysis,
respectively. Naïve ES cells exhibited higher basal and maximal
OCR and ECAR than the 25 h populations, indicating higher levels
of both mitochondrial respiration and glycolysis (Fig. 5C). Within
the 25 h population, 25h-H cells exhibited higher OCR and ECAR
than 25h-L cells (Fig. 5C), indicating that the switch in metabolism
is not a direct response to inhibitor withdrawal but is associated with
a developmental transition. A reduction in mitochondrial respiration
between naïve and primed pluripotent stem cells has been reported
in mouse and human (Takashima et al., 2014; Zhou et al., 2012;
Guo et al., 2016), and has also been proposed to occur in utero
(Zhou et al., 2012). Our analyses indicate that metabolic resetting
begins during transition from naïve pluripotency and initially
involves reduction in both oxidative phosphorylation and
glycolysis.
To benchmark developmental progression, we curated panels of
markers for the following categories: general pluripotency, naïve
pluripotency, post-implantation epiblast and lineage specification.
We then examined expression in our microarray (Fig. 5D, Table S3)
and RNA-seq (Fig. S5B,D, Table S4) datasets. Most naïve
pluripotency TFs were downregulated in reversible cells, and
almost absent in 25h-L cells, in accordance with decay of ES cell
identity. Exceptions were Rex1, Klf5, Fbxo15 and Nr0b1, which
were maintained in reversible cells and reduced but not eliminated
in 25h-L cells (Fig. 5D, Fig. S5B). None of this latter group of
factors is a component of the core gene regulatory circuitry of naïve
pluripotency (Dunn et al., 2014). Among the general pluripotency
markers, Oct4 and Sall4 remained constant, whereas Sox2
transcripts were reduced by 70% on average (Fig. S5B, Table S4)
in 25h-L cells, similar to its downregulation in the epiblast from
E4.5 to E5.5 (Boroviak et al., 2015). Other pluripotency factors,
including Lin28a, Zfp281, Zic2 and Utf1 exhibited upregulation
(Fig. 5D, Fig. S5B). Consistent with increased expression, Lin28a,
Zfp281 and Zic2 are reported to drive transition from naïve to
primed pluripotency (Zhang et al., 2016; Fidalgo et al., 2016; Luo
et al., 2015; Betschinger et al., 2013).
To assess concordance with protein levels, we performed mass
spectrometric analysis via stable isotope labelling of amino acids in
culture (SILAC). These data confirmed that relative nuclear protein
levels of TFs associated with naïve and general pluripotency
correlated with respective transcripts, except for Rex1 and Klf5,
levels of which were not reduced in 25h-L cells, despite decreasing
transcript levels (Fig. S5C).
Factors that are upregulated in the post-implantation epiblast
(Boroviak et al., 2015) [Lef1, Pou3f1 (Oct6), Dnmt3a/b, Foxd3,
Sox3, Fgf5, Cdh2 and Otx2] were progressively induced upon 2i
withdrawal (Fig. 5D, Fig. S5B). A large panel of factors associated
with commitment to germ line, neuroectoderm, endoderm or
mesoderm lineages remained at near-background levels
(RPKM<10) and showed no upregulation beyond levels expressed
in naïve ES cells (Fig. 5D, Fig. S5D). Of note, Gata4 and Gata6 were
not induced in 25h-L cells, excluding primitive endoderm
specification as an alternative path. These results establish that ES
cell exit from naïve pluripotency is temporally segregated from
upregulation of lineage determination factors.
Comparison of ES cell progression with in vivo epiblast,
EpiLCs and EpiSCs
We compared the RNA-seq data from our in vitro populations
(Table S4) with data from embryo samples acquired by a small-
sample RNA-seq protocol (Boroviak et al., 2015). We isolated
expression changes that occur between pre- and post-implantation
epiblast (E4.5 and E5.5), and asked to what extent these are reflected
in the in vitro transition. Out of 608 genes that are differentially
expressed between E4.5 and E5.5 epiblast and robustly detected in
one or both of the samples (FPKM≥10), more than half (366 of 608)
exhibited differential expression during ES cell transition, with the
direction of change conserved (Fig. 6, Table S5). Several functional
groups could be identified within the shared up- and downregulated
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gene sets (Fig. 6A). Besides transcription factors and epigenetic
regulators with established functions in the epiblast, the common
group included genes associated with extracellular matrix (ECM),
cell adhesion, motility, shape, metabolism and autophagy.
Transcripts for ECM components, such as fibronectin (Fn1),
laminin isoforms (Lamc1 and Lama1), the laminin-linker protein
Fig. 5. Transcriptional changes in
ES cells during progression from
naïve pluripotency. (A) Expression
of MEK/ERK and Wnt/β-catenin
transcriptional effectors and targets
from three independent replicates
measured by microarray profiling.
Scale represents log2 transformed
expression value.
(B) Enriched KEGG pathway
categories in the differentially
expressed gene sets ranked
according to P value (P<0.05).
(C) OCR and ECAR levels of 2i
versus 25 h populations (left) and
sorted 25h-H and 25h-L
subpopulations with unsorted whole
population (right) (data are mean±
s.d. from six technical replicates).
(D) Expression of general (red) and
naïve (orange) pluripotency, early
post-implantation (blue) and lineage-
priming factors (black) detected by
microarray. Scale represents log2
transformed expression value.
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Nid1, Spp1 (osteopontin), Sparc, Lgals3 and Alpl were
downregulated, whereas Col18a was upregulated (Fig. 6B),
indicating major reconfiguration of ECM production. Tissue
non-specific alkaline phosphatase (Alpl), which is widely used as a
surrogate marker for ES cells, modifies the ECM by
dephosphorylating ECM molecules such as osteopontin (Spp1)
(Narisawa, 2015).
The LIF receptor components Lifr and Ilst6, the signal
transducers Jak3 and Stat3, and the transcriptional targets Ccnd3,
Klf4 and Tfcp2l1 were downregulated in vitro and in vivo,
indicating that diminished LIF signalling is a common feature in
transition from naïve pluripotency (Fig. 6B). BMP4 and the Nodal
inhibitors Lefty1 and Lefty2 were also downregulated, together
with altered expression of positive and negative regulators of Wnt
signalling. These events highlight a changing signalling context.
We noted changes in enzymes that regulate metabolism and
autophagy. Threonine dehydrogenase (Tdh) was downregulated.
This is a vital enzyme for mouse ES cell survival that converts
threonine into acetyl co-A and glycine, feeding the TCA cycle and
purine synthesis (Wang et al., 2009). Pim2, one of the most highly
upregulated genes in both settings (Fig. 6C), is a kinase that
promotes glycolysis (Yu et al., 2013) and mTOR signalling (Lu
et al., 2013; Zhang et al., 2015). ThemTOR pathway inhibitor Ddit4
(Redd1), and the mTOR activator Rragd were both upregulated.
mTOR signalling is activated during ES cell differentiation
(Betschinger et al., 2013), and it has been reported that mTOR
inhibition induces a diapause-like state of arrested development in
the mouse blastocyst (Bulut-Karslioglu et al., 2016). Pim2, Ddit4
and Rragd are candidates that might contribute to complex mTOR
regulation during this transitional period. Activated mTOR
suppresses autophagy by phosphorylating and inhibiting Ulk1 and
Atg13, two factors that are required for autophagy initiation, and
through phosphorylation-dependent cytoplasmic sequestration of
Tfeb, a TF that orchestrates the expression of genes involved in
lysosome function and autophagy (Kim and Guan, 2015;
Napolitano and Ballabio, 2016). These three mTOR targets, Ulk1,
Fig. 6. Comparison of transcriptional changes during pluripotency progression in ES cells and in the embryo. (A) Functional grouping of genes that show
similar regulation in ES cells and in the embryo. (B) Expression of genes from selected pathways.
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Atg13 and Tfeb, along with several autophagosome-associated
factors were downregulated (Fig. 6B), suggesting transcriptional
and post-transcriptional suppression of autophagy as the cells
transition from naïve pluripotency in vitro and in vivo.
We found that 190 of the 608 genes that show differential
expression during epiblast transition do not change their expression
between 2i ES cells and 25h-L cells, whereas 52 showed differential
expression in the opposite direction to the embryo (Table S5). This
latter subset included the ERK target Egr1 and factors that regulate
cell proliferation (Atf3, Tef, Trp53, Tada3, Klf6 and Ccng1),
apoptosis (Apaf1 and Bid), cell adhesion and morphology (Krt18,
Cdh2, Fez1, Lamb1, Tns3 andAmotl1), as well as signalling pathway
components, such as Notch3, Rbpj and the Nodal co-receptor Tdgf1
(Cripto). Contrasting expression of these genes might reflect
differences in the developmental snapshots sampled in vitro and in
vivo, and/or the absence of paracrine signalling cues in our minimal
culture system. Nonetheless, overall the transcriptome analyses
support the idea that loss of Rex1 expression in a simple and defined
ES cell culture system mimics several features of the developmental
transition from pre- to post-implantation pluripotency.
We also compared 25h-L cells with post-implantation epiblast-
like cells (EpiLCs), a transient intermediate generated during in
vitro germ cell differentiation by plating ES cells from 2i/L into
Fgf2, activin and 1% KSR for 48 h (Hayashi et al., 2011; Buecker
et al., 2014). Differential gene expression analysis showed that
EpiLCs were overall similar to 25h-L cells, and only 183 genes are
differentially expressed between them (Table S6). We also
generated EpiLCs from RGd2 ES cells and measured reporter
expression by flow cytometry. We found that a subpopulation of
EpiLCs (23%) expresses Rex1 at naïve ES cell levels (Fig. S6A,B),
indicating that EpiLC populations are heterogeneous and contain a
substantial fraction of undifferentiated ES cells.
We additionally undertook a comparison with published data
from post-implantation epiblast-derived stem cells (EpiSCs), which
are related to gastrula stage epiblast (Kojima et al., 2014). Marker
expression (Fig. S6C,D) shows that 25h-L cells are related to E5.5
epiblast and are distinct from EpiSCs. These data confirm that ES
cells do not transition directly into EpiSCs (Hayashi et al., 2011;
Smith, 2017).
Acquisition of DNA methylation during transition from naïve
pluripotency
Genome-wide DNA methylation increases substantially between
E4.5 and E5.5 in utero (Auclair et al., 2014). Expression of de novo
DNAmethyltransferases Dnmt3a and Dnmt3b is upregulated both in
ES cells and in the epiblast during transition (Figs 5D, 7A, Fig. S5B).
By contrast, Prdm14, which represses Dnmt3a/b and promotes Tet
activity on target genes (Yamaji et al., 2013; Okashita et al., 2014;
Ficz et al., 2013), is downregulated. Whole-genome bisulfite
sequencing (WGBS) revealed an increase in total CG methylation
across the genome upon 2i withdrawal (Fig. 7B). Average genome
methylation tended to increase in small increments between 2i, 16h
and 25h-H, with a more pronounced and statistically significant
increase at 25h-L. The increasewas similar across gene bodies, exons,
introns, intergenic regions, satellites and retrotransposon sequences
(LINEs, SINEs, LTRs, IAPs), whereas methylation of CpG islands
(CGIs) was not generally altered (Fig. S5A,B). Promoters that contain
CGIs remained refractory to DNA methylation upon 2i withdrawal,
whereas non-CGI promoters exhibited increased methylation similar
to the genome average (Fig. 7C).
Whole-genome methylation data are not available for E5.5
epiblast. We therefore compared our profiles with published data
on E6.5 post-implantation epiblast (Seisenberger et al., 2012).
This analysis showed that the CG methylation level of 25h-L cells
is intermediate between naïve ES cells and E6.5 post-implantation
epiblast across all genomic regions (Fig. 7, Fig. S7). This is in line
with reduced representation bisulfite sequencing (RRBS) data on
embryos that shows a marked increase in methylation between
E4.5 and E5.5 with a further increase at E6.5 (Auclair et al.,
2014).
To investigate how DNA methylation might relate to gene
expression changes during exit from the naïve state, we examined
enhancers. We identified ‘naïve enhancers’ from published ChIP-
seq datasets from naïve ES cells (Table S8) (Buecker et al., 2014) as
regions displaying the general enhancer mark H3K4me1, together
with the active enhancer marks H3K27Ac and p300 (Visel et al.,
2009; Rada-Iglesias et al., 2011; Heintzman et al., 2007; Visel et al.,
2013; Blow et al., 2010). In 2i, these enhancers were lowly
methylated, but they gained methylation progressively upon 2i
withdrawal (Fig. 7D). By contrast, ES cell ‘super enhancers’ (SEs)
defined in serum-cultured ES cells (Whyte et al., 2013; Hnisz et al.,
2013) exhibited low and relatively constant methylation levels in 2i,
16h and 25h-H cells, with a small increase in 25h-L cells but below
the genome average (Fig. 7D). These observations indicate that, on
exit from naïve pluripotency, naïve enhancers are methylated, which
is indicative of decommissioning, whereas SEs that may be linked to
general pluripotency-associated transcription are protected from
methylation.
We compared our WGBS data with published RRBS data from
E4.5 and E5.5 epiblasts (Auclair et al., 2014), and Rex1-sorted
subpopulations of serum-cultured RGd2 ES cells (Singer et al.,
2014) (Table S9). This analysis is limited to promoters and CGIs
that are covered in all datasets, because RRBS enriches for genomic
regions with high CpG content (Meissner et al., 2005). The vast
majority of CGIs and CG-rich promoters in epiblast samples
exhibited less than 5% methylation (Fig. S8A, Table S9). This was
matched in 2i and 25h-L cells. By contrast both Rex1-high and
Rex1-low fractions of serum-cultured ES cells exhibited higher
levels of methylation. Therefore, we did not include serum ES cell
samples in further analyses. Most promoters gained less than 5%
methylation during ES cell and epiblast transitions (Fig. S8B). We
asked whether those that do gain methylation are conserved between
in vivo and in vitro settings. We isolated 2000 promoters with the
highest methylation increases (Table S10). Interestingly, these
promoters had higher methylation relative to all other promoters in
naïve ES cells and epiblast (Fig. S8C). The majority were associated
with lowly expressed or non-expressed genes (Table S10). In the
common group of 1288 promoters were only 52 associated genes
that are expressed in both in ES cell populations and the epiblast
(Fig. S8D). A subset of these genes exhibited downregulation both
in ES cell and epiblast progression. Among these are Tdh, Lefty1,
Tcl1 and Prdm14.
WGBS analysis also showed no genome-wide correlation
between promoter methylation and gene expression changes.
Nonetheless, we noted increased methylation in a subset of naïve
pluripotency gene promoters, including Nanog, Nr0b1 and Dppa3,
in addition to Prdm14 and Tcl1, as noted above (Fig. 7E, Fig. S8E).
Promoters of other naïve and general pluripotency factors did not
gain methylation, showing that pluripotency-associated genes
acquire methylation with different kinetics. Thus, we conclude
that promoter methylation is not a major driver of transcriptional
changes during exit from the naïve state, although it might
contribute to repression of a subset of genes that are of potential
functional significance for the transition.
1229












The RGd2 reporter provides near real-time detection of exit from
naïve pluripotency and enables isolation of the first cells to change
functional identity. Loss of Rex1 expression marks a progression in
pluripotent status that precedes a decline in Oct4 level or acquisition
of lineage-specific gene expression. Our results characterise a
defined in vitro monolayer differentiation system in the absence of
uterine or extraembryonic cues. In these simple conditions autocrine
signals are sufficient to drive transcriptomic, metabolic and
methylome changes that are broadly convergent with peri-
implantation epiblast. These findings indicate that the gene
regulatory circuitry of ES cells has an innate capacity to
orchestrate a profound developmental transition.
At the onset of this transition, the molecular network that sustains
naïve pluripotency is dismantled (Buecker et al., 2014; Kalkan and
Smith, 2014; Leeb et al., 2014). Apparently co-incident with acute
downregulation of the critical naïve TFs, post-implantation epiblast
markers are up-regulated (Acampora et al., 2016; Boroviak et al.,
2015). Increased differentiation when transferred to serum suggests
enhanced sensitivity to inductive cues before cells have fully
extinguished ES cell identity. However, for as long as Rex1 is
expressed, cells retain in full the ability to regain the ground state. Such
reactivation of self-renewal, despite marked reduction in the levels of
functionally important naïve TFs, is consistent with evidence that the
mouse ES cell state is founded on a highly flexible transcription factor
circuitry (Dunn et al., 2014; Martello and Smith, 2014; Young, 2011;
Niwa, 2014). We surmise that loss of Rex1 reflects a cumulative
reduction of the suite of factors below a critical threshold. From this
point, the naïve TF network cannot be reactivated and is subsumed by
an emerging new circuitry. The apparent gradual loss of self-renewal
gleaned from whole population analyses arises from asynchronous
single cell dynamics and at the level of individual cells the exit fromES
cell identity may be precipitate.
Rex1 transcription is considered to be directly regulated by
several naïve TFs (Chen et al., 2008; Kim et al., 2008) which can
explain how the RGd2 reporter serves as a sensor of the overall
activity of the naïve transcription factor circuitry. Nevertheless,
10-15% of the Rex1-low cells at 25 h can be restored to ground state
self-renewal. This may be explained in part by incomplete
efficiency of flow sorting, but also suggests that Rex1
Fig. 7. Acquisition of DNA methylation during transition from naïve pluripotency. (A) mRNA expression of factors that modulate DNA methylation.
(B) Global genomic methylation in CG context (mCG) in 2 kb tiles. ns, non significant, *P<0.05 (one-way multiple comparisons ANOVA corrected with Tukey’s
test). (C,D) Percentage of mCG (C) in the promoters (−1000 bp to +500 bp of TSS) of expressed genes (RPKM≥10), (D) in genome-wide naïve and super
enhancers and (E) in the promoters of selected pluripotency-associated genes.
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downregulation might be separated from exit in a minority of cells.
The higher incidence of reversion for Rex1-Low cells at 20 h is
consistent with silencing of Rex1 slightly preceding loss of ES cell
identity. Reversibility of Rex1 reporter expression has been reported
in serum (Toyooka et al., 2008), where ES cells are continuously
exposed to conflicting pro- and anti-differentiation stimuli that may
perturb developmental progression. Even in those conditions,
however, it is apparent that with more stringent categorisation of
Rex1-negative cells, reversion frequency is low (Nakai-Futatsugi
and Niwa, 2016). Furthermore, Rex1-negative cells from serum
culture tend to be eliminated from blastocyst chimaeras, indicating
limited identity with resident epiblast (Alexandrova et al., 2016;
Toyooka et al., 2008). Nonetheless, the connection between down-
regulation of naïve factors and loss of Rex1-GFP may not be
invariant. Indeed, rare Nanog-positive/GFP-negative cells are
detected at 25 h.
Consistent with loss of functional ES cell character, the 25h-L
population show significant transcriptome variance from their
naïve predecessors. They are clearly distinct from EpiSCs, and
converge towards EpiLC and E5.5 epiblast. It will be of interest to
determine to what extent micro-environmental modulations, such
as substrate composition, may increase the veracity of the ES cell
model.
The dynamic and global increase in DNAmethylation as ES cells
leave the naïve state generate a methylome intermediate between
naïve and primed pluripotent compartments. We detected profound
increases in the methylation levels of naïve ES cell enhancers and in
a minority of promoters. However, there was no overall correlation
between promoter methylation and gene expression, as also
observed when ES cell cultures were switched between 2i and
serum (Ficz et al., 2013; Habibi et al., 2013). Thus, increased
promoter methylation does not appear to be a major driver of initial
progression from naïve pluripotency. Indeed most pluripotency
gene promoters were spared from methylation, although Nanog
and Prdm14 were prominent exceptions that gained methylation in
25h-L cells.
We have proposed that downregulation of naïve pluripotency
factors elicits differentiation competence via an intermediate phase
of “formative pluripotency” (Kalkan and Smith, 2014; Smith, in
press). This is postulated as a period of competence acquisition for
multi-lineage specification. In vivo the formative phase corresponds
to peri- and immediate post-implantation epiblast (E4.75-5.75),
before cells exhibit expression of lineage specification factors.
Notably during this period epiblast cells acquire competence for
germ cell induction (Ohinata et al., 2009; Hayashi et al., 2011). Our
results indicate that ES cells that downregulate Rex1 and depart
naïve pluripotency show transcriptome and methylome features that
may be anticipated for immediate post-implantation epiblast. Thus,
these Rex1-low cells represent a snapshot of the nascent formative
phase, undergoing rewiring of the gene regulatory network and
remodelling of the epigenome. The datasets we provide constitute a
resource for inspecting an overlooked phase of pluripotency. It will
be of future interest to dissect in detail the molecular dynamics and
drivers of transition in this defined and simple system and also to
determine whether the formative phase may be suspended as a stem
cell state in culture, as achieved for naïve ES cells and primed
EpiSCs.
MATERIALS AND METHODS
ES cell lines and culture
ES cell lines carrying the RGd2 reporter were derived from embryos using
previously described protocols (Nichols et al., 2009). For routine
maintenance, ES cells were plated at 2-3×104 cells cm−2 in 2i on 0.1%
gelatine-coated dishes (Sigma, G1890) and passaged every 3 days following
dissociation with Accutase (PAA, L11-007). 2i consists of N2B27 (NDiff
N2B27 base medium, Stem Cell Sciences, SCS-SF-NB-02) or lab-made
N2B27, supplemented with PD0325901 (1 μM) and CHIR99021 (3 μM).
LIF prepared in-house was added only when indicated.
Immunofluorescent stainingof EScells and imagequantification
Cells were fixed for 10 min with 4% PFA at room temperature, followed by
permeabilisation and blocking in PBS containing 0.1%TritonX-100 and 3%
donkey serum. Cells were incubated with primary antibodies (Table S7) in
blocking solution overnight at 4°C. Alexa Fluor-conjugated donkey
secondary antibodies (Molecular Probes) were used at 1:1000. For
confocal microscopy imaging, ES cells were plated onto dishes with
ibiTreat surface (Ibidi). Images were obtained using Leica SP5 confocal
microscope for Fig. S2 and Leica 4000B standard fluorescent microscope
for all other figures. Mean immunofluorescence (IF) and DAPI intensity per
cell was quantified using Volocity (Fig. 3) and Cell Profiler (Fig. S2). For
Fig. 3, cells were ordered according to increasing mean IF intensity in
DAPI-positive particles and then consecutive 25, 50 and 25 percentiles of
positive cells were labelled as low, mid and high for a particular marker.
Monolayer differentiation, flow cytometry, cell sorting and
clonogenicity assays
Cells were plated at 1.5×104 cells cm−2 in 2i and medium was replaced with
N2B27 or fresh 2i after 20-24 h. Prior to sorting, cells were washed, pelleted
and resuspended in the respective culture medium. For dissociation of 2i
cells, 2i inhibitors were added into Accutase. ToPro-3 (Invitrogen) was
added at a concentration of 0.05 nM to label membrane-compromised cells.
Cells were sorted in MoFlo flow sorter (Beckman Coulter). From 2i- and
16 h-cultures, all ToPro-3-negative cells were collected. To obtain Rex1-
high and Rex1-low fractions from 25 h-cultures, sorting gates were set to
collect cells with highest and lowest 15%GFP expression. For clonogenicity
assays, 500 or 800 cells, as indicated in the figure legends, were plated on
six-well dishes in Serum/L or 2i/L and coated with 0.1% gelatine or laminin
(Sigma, L2020), respectively. On days 4 (Serum/L) or 6 (2i/L), plates were
fixed and stained for AP (Sigma, 86R-1KT). Plates were scanned using a
Cell Celector (Aviso) and scored manually. Colony formation efficiency for
a given population was determined by dividing the average number of
colonies formed in 2i/L by that in Serum/L. Flow cytometry was performed
using a Dako Cytomation CyAn ADP high-performance cytometer and
results were analysed using Summit.
RNA extraction, cDNA synthesis and qPCR
Total RNA was isolated using RNeasy mini kit (Qiagen). cDNA was
synthesised using SuperScript III (Invitrogen) and oligo-dT primers.
qRT-PCR was performed with TaqMan Gene Expression assays (Thermo
Scientific) using probes listed in Table S7.
Single cell RT-qPCR
Cells were sorted using a G1 enrichment strategy, based on forward scatter
(FS) and side scatter (SC) gating. Single cells were sorted into 96-well plates
containing CellsDirect One-Step qRT-PCR master mix (Invitrogen, 11753-
100) for cDNA synthesis and pre-amplification. Fluidigm assays were
performed according to the manufacturer’s protocols using EvaGreen
detection at the Genomics Core Facility at the European Molecular Biology
Laboratory in Heidelberg, Germany. Primer sets used are listed in Table S7.
Protein analysis by mass spectrometry
Nuclear fractions from naïve ES cells and transiting populations were
subjected to proteomic analysis by mass spectrometry using SILAC, as
described in the supplementary Materials and Methods.
Detection of OCR and ECAR by extracellular flux analysis
Extracellular flux analysis was carried out using the Mito Stress Assay in a
Seahorse XFe24 Analyzer, according to the manufacturer’s protocol (Agilent
Technologies). See supplementary Materials and Methods for details.
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ES cells were subjected to the standard differentiation protocol (Fig. 4A).
Six hours after medium switch to 2i or N2B27, cycloheximide (Sigma,
C4859) (100 µg/ml) or DMSO (control) was added into the media.
Immunoblots
Western blots were performed on total cell lysates as described in the
supplementary Materials and Methods.
Mouse colony establishment and immunostaining of embryos
Mice carrying the Rex1-GFPd2 reporter were generated as described in the
supplementary Materials and Methods.
Microarray, RNA-sequencing, DNA methylome and proteome
analyses
Processing of ES cell samples and data analyses are described in the
supplementary Materials and Methods.
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Respuela, P., Nikolić, M., Tan, M., Frommolt, P., Zhao, Y., Wysocka, J. and
Rada-Iglesias, A. (2016). Foxd3 promotes exit from naive pluripotency through
enhancer decommissioning and inhibits germline specification.Cell Stem Cell 18,
118-133.
Rezende, N. C., Lee, M.-Y., Monette, S., Mark, W., Lu, A. and Gudas, L. J.
(2011). Rex1 (Zfp42) null mice show impaired testicular function,
abnorma testis morphology, and aberrant gene expression. Dev. Biol. 356,
370-382.
Seisenberger, S., Andrews, S., Krueger, F., Arand, J., Walter, J., Santos, F.,
Popp, C., Thienpont, B., Dean, W. and Reik, W. (2012). The dynamics of
genome-wide DNA methylation reprogramming in mouse primordial germ cells.
Mol. Cell 48, 849-862.
Singer, Z. S., Yong, J., Tischler, J., Hackett, J. A., Altinok, A., Surani, M. A., Cai,
L. and Elowitz, M. B. (2014). Dynamic heterogeneity and DNA methylation in
embryonic stem cells. Mol. Cell 55, 319-331.
Smith, A. (2017). Formative pluripotency: the executive phase in a developmental
continuum. Development 144, 365-373.
Smith, Z. D., Chan, M. M., Mikkelsen, T. S., Gu, H., Gnirke, A., Regev, A. and
Meissner, A. (2012). A unique regulatory phase of DNA methylation in the early
mammalian embryo. Nature 484, 339-344.
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